Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer.

Campisi M, Osaki T, Dryg I, Stornante C, Wolff J, Weirather J, Weaver N, Tarannum M, Gillanders I, Bers A, Bobilev E, Lineberry MS, Schol P, Chen M, Ota K, Park SR, Fahey CG, Thai TC, Li Y, Li Z, Li ZH, Shelton S, Hirose S, Padrick C, Ivanova E, Ha M, Yang S, Olszewski H, Kivlehan S, Lizotte P, Hagen K, Gjeci I, Haller W, Zasadil LM, El Zarif T, Berchuck JE, Knelson EH, Brea EJ, Odintsov I, Liu T, Chiono V, Tuladhar B, Ngo K, Rosentrater E, Raizer J, Lineberry N, Sur M, Pfaff K, Freedman M, Hodi FS, Tolstorukov MY, Oser MG, Sheffer M, Mitsiades CS, Barnes MJ, Appleman VA, Gokhale PC, Kamm RD, Paweletz CP, Romee R, Rodig S, Barbie DA, Mahadevan NR